Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
VolitionRx Limited Announces Strategic Acquisition
2019-12-16 21:30
VolitionRx and Gyros Protein Technologies Awarded an Aggregate $1 million+ Eurostars Cash Grant to Collaborate on Developing a Lung Cancer Blood Test
2019-12-05 21:30
VolitionRx Limited Announces Proof of Concept Data in Lymphoma and Leukemia
2019-12-03 21:30
VolitionRx Limited Schedules Third Quarter 2019 Earnings Conference Call and Business Update
2019-11-07 21:30
Volition announces $500,000 in Non-Dilutive Funding for Volition Veterinary and issues Video
2019-10-29 20:30
Texas A&M University Takes A 12.5% Equity Stake in Volition Veterinary Diagnostics Development LLC
2019-10-26 00:00
Nu.Q(TM) Vet Pre-Analytical Data to be Presented at the Veterinary Cancer Society Annual Conference in Houston, Texas
2019-10-18 20:30
Volition Appoints Dr. Phillip Barnes to Board of Directors
2019-10-10 04:05
Volition Announces Breakthrough in Enrichment of Tumor Nucleosomes
2019-09-17 20:35
Volition Forms Texas-Based Veterinary Subsidiary and Appoints its Chief Executive Officer
2019-08-08 20:30
VolitionRx Limited Schedules Second Quarter 2019 Earnings Conference Call and Business Update
2019-08-07 20:45
Volition Announces Exercise of Warrant to Purchase $4.8 Million in Common Stock
2019-07-25 04:05
VolitionRx Limited Commences Lung Cancer Clinical Study with Fosun Long March in China
2019-07-18 20:30
VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding
2019-07-10 20:30
VolitionRx Limited Schedules First Quarter 2019 Earnings Conference Call and Business Update
2019-05-07 04:05
VolitionRx Limited Signs Memorandum of Understanding with Texas A&M University for Potential Collaboration to Develop Nu.QTM Veterinary Diagnostics
2019-04-09 20:30
VolitionRx Limited Signs Memorandum of Understanding with Fosun Long March in China
2019-03-28 22:48
VolitionRx Limited to Present at Conferences in March & April 2019
2019-03-25 20:40
VolitionRx Limited to Present at Conferences in the U.S. Next Week
2019-03-15 20:30
VolitionRx Limited Announces Full Fiscal Year 2018 Financial Results and Business Update
2019-03-14 04:05
1
2
3
4
5
6
7